GPC3 and neoplasm: These results suggest that irradiation does not compromise the anti-tumor efficacy of NK92MI/HN3 cells, as the irradiated NK92MI/HN3 cells displayed similar anti-GPC3 malignancy activity to unirradiated NK92MI/HN3 cells.